IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novus Therapeutics Inc

CUSIP: 67011N105 | 54 institutional holders

Quarters

Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2020

Asymmetry Capital Management, L.P.80,069
0.0% of portfolio›$1.2K
StyleTurnoverLocationFiled
Asymmetry Capital Management, L.P.
80,069$1.2K0.0%N/AN/ASan Francisco, CA2021-02-11